SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-011029
Filing Date
2017-02-24
Accepted
2017-02-24 17:24:48
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F v460184_20f.htm 20-F 1245677
2 EXHIBIT 12.1 v460184_ex12-1.htm EX-12.1 8215
3 EXHIBIT 12.2 v460184_ex12-2.htm EX-12.2 8190
4 EXHIBIT 13.1 v460184_ex13-1.htm EX-13.1 4465
5 EXHIBIT 13.2 v460184_ex13-2.htm EX-13.2 4551
6 EXHIBIT 15.1 v460184_ex15-1.htm EX-15.1 3846
7 GRAPHIC logo_20f.jpg GRAPHIC 2077
8 GRAPHIC pg04img01_20f.jpg GRAPHIC 10449
9 GRAPHIC pg40img01_20f.jpg GRAPHIC 74125
10 GRAPHIC pg41img01_20f.jpg GRAPHIC 119160
  Complete submission text file 0001144204-17-011029.txt   5526743

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT orpn-20161231.xml EX-101.INS 1116457
12 XBRL TAXONOMY EXTENSION SCHEMA orpn-20161231.xsd EX-101.SCH 42487
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orpn-20161231_cal.xml EX-101.CAL 41257
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orpn-20161231_def.xml EX-101.DEF 235959
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE orpn-20161231_lab.xml EX-101.LAB 279778
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orpn-20161231_pre.xml EX-101.PRE 292230
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 17638652
SIC: 2834 Pharmaceutical Preparations